Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0001209191-23-039133 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-22 | 2023-06-20 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +22.4K | 117.1K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-20 | A | A | 22,350 | $0.00 | 117,132 | D | — | — |